share_log

Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'

Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'

吉姆·克萊默說雪佛龍的表現 “相當不錯”,將給這家制藥巨頭一個 “機會”
Benzinga ·  04/01 09:00

On CNBC's "Mad Money Lightning Round," Jim Cramer said Core & Main, Inc. (NYSE:CNM) is "right at the heart of this infrastructure bull market I keep talking about because it does waste water. It is perfectly positioned...even though it's just been a horse, it can go higher."

在CNBC的 “瘋狂金錢閃電回合” 中,吉姆·克萊默說,Core & Main, Inc.(紐約證券交易所代碼:CNM)“是我一直在談論的基礎設施牛市的核心,因爲它確實會浪費水。它的位置非常完美... 儘管它只是一匹馬,但它可以飛得更高。”

On March 19, Core & Main reported upbeat sales results for its fourth quarter. The company posted quarterly earnings of 34 cents per share, missing analysts' estimates of 35 cents per share. The company's quarterly sales came in at $1.44 billion, versus expectations of $1.43 billion, according to data from Benzinga Pro.

3月19日,Core & Main公佈了樂觀的第四季度銷售業績。該公司公佈的季度每股收益爲34美分,未達到分析師預期的每股35美分。根據Benzinga Pro的數據,該公司的季度銷售額爲14.4億美元,而預期爲14.3億美元。

KLA Corporation (NASDAQ:KLAC) is a "very good" company, Cramer said.

克萊默說,KLA公司(納斯達克股票代碼:KLAC)是一家 “非常好” 的公司。

On March 25, Stifel analyst Brian Chin reiterated KLA with a Buy and maintained a $685 price target.

3月25日,Stifel分析師布萊恩·欽重申了KLA的買入並維持了685美元的目標股價。

Chevron Corporation (NYSE:CVX) has got a 4% yield and is doing "pretty well," Cramer said, "That's Mike Wirth's company, I'm not going to leave it here."

克萊默說,雪佛龍公司(紐約證券交易所代碼:CVX)的收益率爲4%,並且表現 “相當不錯”,“那是邁克·沃思的公司,我不會把它留在這裏。”

On March 18, Chevron's Chevron New Energies inked a signed Memorandum Of Understanding with JX Nippon Oil & Gas Exploration Corporation to develop the CCS value chain.

3月18日,雪佛龍旗下的雪佛龍新能源與日本石油天然氣勘探公司簽署了諒解備忘錄,以開發CCS價值鏈。

"Let's give Pfizer a chance. They've got this really good acquisition that I like of Seagen. Let's give it some time here," Cramer said when asked about Pfizer Inc. (NYSE:PFE).

“讓我們給輝瑞一個機會。他們對西根進行了這次非常不錯的收購,我非常喜歡。讓我們在這裏等一會兒。” 當被問及輝瑞公司(紐約證券交易所代碼:PFE)時,克萊默說。

On March 22, Argus Research analyst David Toung downgraded Pfizer from Buy to Hold.

3月22日,阿格斯研究分析師大衛·湯將輝瑞的評級從買入下調至持有。

The "Mad Money" host said Leidos Holdings, Inc. (NYSE:LDOS) is a winner. "It's a defense contractor that's actually not struggling to get money out of Congress," he added.

這位 “瘋狂的錢” 主持人說,萊多斯控股公司(紐約證券交易所代碼:LDOS)是贏家。他補充說:“這是一家國防承包商,實際上並不難以從國會獲得資金。”

On March 27, B of A Securities analyst Mariana Perez maintained Leidos Holdings with a Buy and raised the price target from $125 to $145.

3月27日,B of A Securities分析師瑪麗安娜·佩雷斯維持萊多斯控股的買入,並將目標股價從125美元上調至145美元。

"People like these things, people like these bulk carriers right now," Cramer said when asked about SFL Corporation Ltd. (NYSE:SFL). "Do not overstay your welcome in this, it's been a big run. But it's going to go a little higher."

當被問及SFL有限公司(紐約證券交易所代碼:SFL)時,克萊默說:“人們喜歡這些東西,現在人們喜歡這些散裝貨船。”“在這場比賽中,不要過分歡迎你的到來,這是一場大獲成功。但它會更高一點。”

On Feb. 14, SFL posted better-than-expected results for its fourth quarter.

2月14日,SFL公佈的第四季度業績好於預期。

Price Action:

價格走勢:

  • Shares of Core & Main gained 0.9% to close at $57.25 on Thursday.
  • Pfizer shares fell 0.1% to close at $27.75.
  • SFL shares gained 0.5% to settle at $13.18 on Thursday.
  • Leidos shares gained 0.4% to close at $131.09 during Thursday's session.
  • KLA shares gained 0.2% to settle at $698.57.
  • Shares of Chevron gained 0.9% to close at $157.74 on Thursday.
  • 週四,Core & Main的股價上漲0.9%,收於57.25美元。
  • 輝瑞股價下跌0.1%,收於27.75美元。
  • 週四,SFL股價上漲0.5%,收於13.18美元。
  • 在週四的交易中,萊多斯股價上漲0.4%,收於131.09美元。
  • KLA股價上漲0.2%,收於698.57美元。
  • 雪佛龍股價週四上漲0.9%,收於157.74美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論